{"component": "clause", "props": {"groups": [{"size": 12, "snippet_links": [{"key": "payments-under-this-agreement", "type": "clause", "offset": [4, 33]}, {"key": "by-wire-transfer", "type": "clause", "offset": [129, 145]}, {"key": "automated-clearing-house", "type": "definition", "offset": [149, 173]}, {"key": "payment-to", "type": "clause", "offset": [180, 190]}, {"key": "by-company", "type": "clause", "offset": [213, 223]}, {"key": "from-time-to-time", "type": "clause", "offset": [258, 275]}, {"key": "in-writing", "type": "clause", "offset": [276, 286]}], "snippet": "All payments under this Agreement are expressed in U.S. Dollars and will be paid in U.S. Dollars, in immediately available funds by wire transfer or Automated Clearing House (ACH) payment to an account designated by Company (which account Company may update from time to time in writing).", "samples": [{"hash": "eCJ0VcO6LFt", "uri": "/contracts/eCJ0VcO6LFt#currency-payment-method", "label": "Strategic Collaboration and License Agreement (Entrada Therapeutics, Inc.)", "score": 35.1957550049, "published": true}, {"hash": "d3aecxQAZZZ", "uri": "/contracts/d3aecxQAZZZ#currency-payment-method", "label": "Sublicense Agreement (Entrada Therapeutics, Inc.)", "score": 35.1957550049, "published": true}, {"hash": "i79lGbETMN3", "uri": "/contracts/i79lGbETMN3#currency-payment-method", "label": "Strategic Collaboration and License Agreement (Entrada Therapeutics, Inc.)", "score": 34.3524971008, "published": true}], "hash": "44570c27472969afe91fd03e1f121f8d", "id": 1}, {"size": 3, "snippet_links": [{"key": "payments-under-this-agreement", "type": "clause", "offset": [4, 33]}, {"key": "by-wire-transfer", "type": "clause", "offset": [98, 114]}, {"key": "automated-clearing-house", "type": "definition", "offset": [118, 142]}, {"key": "payment-to", "type": "clause", "offset": [149, 159]}, {"key": "from-time-to-time", "type": "clause", "offset": [225, 242]}, {"key": "in-writing", "type": "clause", "offset": [243, 253]}], "snippet": "All payments under this Agreement are expressed in U.S. Dollars and will be paid in U.S. Dollars, by wire transfer or Automated Clearing House (ACH) payment to an account designated by Kymera (which account Kymera may update from time to time in writing).", "samples": [{"hash": "83WWYAOgLcb", "uri": "/contracts/83WWYAOgLcb#currency-payment-method", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 35.1409988403, "published": true}, {"hash": "l3SeuC4QJiw", "uri": "/contracts/l3SeuC4QJiw#currency-payment-method", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 34.1444206238, "published": true}, {"hash": "3ebf1sSqNAi", "uri": "/contracts/3ebf1sSqNAi#currency-payment-method", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 31.5790557861, "published": true}], "hash": "17489922870533edf275339bce1bb33e", "id": 2}, {"size": 3, "snippet_links": [{"key": "dollar-amounts", "type": "definition", "offset": [4, 18]}, {"key": "in-this-agreement", "type": "definition", "offset": [31, 48]}, {"key": "united-states-dollars", "type": "clause", "offset": [53, 74]}, {"key": "payments-to", "type": "clause", "offset": [80, 91]}, {"key": "in-united-states", "type": "clause", "offset": [131, 147]}, {"key": "by-check", "type": "clause", "offset": [156, 164]}, {"key": "rd-products", "type": "definition", "offset": [225, 237]}, {"key": "conversion-rate", "type": "clause", "offset": [346, 361]}, {"key": "the-foreign-currency", "type": "definition", "offset": [366, 386]}, {"key": "the-wall-street-journal", "type": "clause", "offset": [426, 449]}, {"key": "day-of", "type": "clause", "offset": [474, 480]}, {"key": "the-applicable", "type": "clause", "offset": [481, 495]}, {"key": "calendar-quarter", "type": "clause", "offset": [496, 512]}], "snippet": "All dollar amounts referred to in this AGREEMENT are United States dollars. All payments to VGX under this AGREEMENT shall be made in United States dollars by check or wire-transfer. If VI receives revenues from SALES of VGX R&D PRODUCTS in currency other than United States Dollars, revenues shall be converted into United States dollars at the conversion rate for the foreign currency as published in the eastern edition of The Wall Street Journal as of the last business day of the applicable CALENDAR QUARTER.", "samples": [{"hash": "fe1WyHlU9II", "uri": "/contracts/fe1WyHlU9II#currency-payment-method", "label": "R&d Collaboration and License Agreement (Inovio Biomedical Corp)", "score": 21.0, "published": true}, {"hash": "cjlF56MNFlg", "uri": "/contracts/cjlF56MNFlg#currency-payment-method", "label": "R&d Collaboration and License Agreement (Inovio Biomedical Corp)", "score": 21.0, "published": true}], "hash": "696aa895588bd58bcb967baf4a528a06", "id": 3}, {"size": 2, "snippet_links": [{"key": "payments-under-this-agreement", "type": "clause", "offset": [4, 33]}, {"key": "by-wire-transfer", "type": "clause", "offset": [129, 145]}, {"key": "automated-clearing-house", "type": "definition", "offset": [149, 173]}, {"key": "the-bank-account", "type": "clause", "offset": [191, 207]}, {"key": "the-party", "type": "clause", "offset": [239, 248]}, {"key": "such-party", "type": "clause", "offset": [288, 298]}, {"key": "from-time-to-time", "type": "clause", "offset": [310, 327]}, {"key": "in-writing", "type": "clause", "offset": [328, 338]}, {"key": "in-this-agreement", "type": "definition", "offset": [365, 382]}, {"key": "each-party-will", "type": "clause", "offset": [384, 399]}, {"key": "undisputed-amounts", "type": "clause", "offset": [408, 426]}, {"key": "other-party", "type": "definition", "offset": [461, 472]}, {"key": "receipt-of", "type": "clause", "offset": [501, 511]}], "snippet": "All payments under this Agreement are expressed in U.S. Dollars and will be paid in U.S. Dollars, in immediately available funds by wire transfer or Automated Clearing House (ACH) payment to the bank account designated in Schedule 9.15 by the Party receiving such payments (which account such Party may update from time to time in writing). Unless stated otherwise in this Agreement, each Party will pay the undisputed amounts of each invoice received from the other Party within [***] days following receipt of such invoice.", "samples": [{"hash": "5XytNj1997c", "uri": "/contracts/5XytNj1997c#currency-payment-method", "label": "Collaboration and License Agreement (Gossamer Bio, Inc.)", "score": 33.611907959, "published": true}], "hash": "d88de2a2e4610066caf324c37f5c4bda", "id": 4}, {"size": 2, "snippet_links": [{"key": "dollar-amounts", "type": "definition", "offset": [10, 24]}, {"key": "in-this-agreement", "type": "definition", "offset": [37, 54]}, {"key": "united-states-dollars", "type": "clause", "offset": [59, 80]}, {"key": "payments-to", "type": "clause", "offset": [86, 97]}, {"key": "in-united-states", "type": "clause", "offset": [137, 153]}, {"key": "by-check", "type": "clause", "offset": [162, 170]}, {"key": "payable-to", "type": "definition", "offset": [171, 181]}, {"key": "licensed-products", "type": "definition", "offset": [257, 274]}, {"key": "conversion-rate", "type": "clause", "offset": [383, 398]}, {"key": "the-foreign-currency", "type": "definition", "offset": [403, 423]}, {"key": "the-wall-street-journal", "type": "clause", "offset": [463, 486]}, {"key": "day-of", "type": "clause", "offset": [511, 517]}, {"key": "the-applicable", "type": "clause", "offset": [518, 532]}, {"key": "calendar-quarter", "type": "clause", "offset": [533, 549]}, {"key": "due-date", "type": "definition", "offset": [623, 631]}, {"key": "equal-to", "type": "definition", "offset": [654, 662]}, {"key": "per-month", "type": "clause", "offset": [695, 704]}, {"key": "maximum-allowed", "type": "clause", "offset": [709, 724]}], "snippet": "4.4.1 All dollar amounts referred to in this AGREEMENT are United States dollars. All payments to INO under this AGREEMENT shall be made in United States dollars by check payable to \u201cInovio Pharmaceuticals, Inc.\u201d If VGXI receives revenues from SALES of INO LICENSED PRODUCTS in currency other than United States dollars, revenues shall be converted into United States dollars at the conversion rate for the foreign currency as published in the eastern edition of The Wall Street Journal as of the last business day of the applicable CALENDAR QUARTER.\n4.4.2 Amounts that are not paid when due shall accrue interest from the due date until paid, at a rate equal to one and one-half percent (1.5%) per month (or maximum allowed by law, if less).", "samples": [{"hash": "8nEGIrXOqm0", "uri": "/contracts/8nEGIrXOqm0#currency-payment-method", "label": "Collaboration and License Agreement (Inovio Pharmaceuticals, Inc.)", "score": 22.8480491638, "published": true}], "hash": "760f068d6ee3e507717285fcb610ebfd", "id": 5}, {"size": 1, "snippet_links": [{"key": "payments-under-this-agreement", "type": "clause", "offset": [4, 33]}, {"key": "transfer-to", "type": "definition", "offset": [72, 83]}, {"key": "from-time-to-time", "type": "clause", "offset": [149, 166]}, {"key": "in-writing", "type": "clause", "offset": [167, 177]}, {"key": "upon-written-notice", "type": "clause", "offset": [180, 199]}, {"key": "direct-or-indirect", "type": "clause", "offset": [220, 238]}, {"key": "permitted-assignee", "type": "clause", "offset": [239, 257]}, {"key": "the-rights", "type": "clause", "offset": [284, 294]}, {"key": "future-payments", "type": "definition", "offset": [320, 335]}, {"key": "contemplated-by-this-agreement", "type": "clause", "offset": [336, 366]}, {"key": "reports-required", "type": "clause", "offset": [394, 410]}, {"key": "in-accordance-with", "type": "definition", "offset": [432, 450]}, {"key": "addressed-to", "type": "definition", "offset": [520, 532]}, {"key": "accounts-payables", "type": "clause", "offset": [545, 562]}, {"key": "with-a-copy-to", "type": "clause", "offset": [638, 652]}, {"key": "alliance-management", "type": "clause", "offset": [665, 684]}], "snippet": "All payments under this Agreement will be paid in U.S. Dollars, by wire transfer to an account designated by Vertex (which account Vertex may update from time to time in writing). Upon written notice from Vertex (or any direct or indirect permitted assignee, transferee or pledgee of the Rights), Merck will deliver any future payments contemplated by this Agreement, together with the royalty reports required under Section 5.2.7, in accordance with the directions in such written notice. Invoices from Vertex shall be addressed to: Merck KGaA Accounts Payables \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587.\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587@\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 With a copy to: Merck KGaA Alliance Management Healthcare \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 Attn.: \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587, Director", "samples": [{"hash": "fw1aDph8RRH", "uri": "/contracts/fw1aDph8RRH#currency-payment-method", "label": "Strategic Collaboration and License Agreement (Vertex Pharmaceuticals Inc / Ma)", "score": 28.3210124969, "published": true}], "hash": "197e471c7bd4ede1248703a8a4405587", "id": 6}, {"size": 1, "snippet_links": [{"key": "transfer-in", "type": "definition", "offset": [63, 74]}, {"key": "immediately-available-funds", "type": "definition", "offset": [75, 102]}], "snippet": "Any royalties due to KIT will be paid in U.S. dollars, by wire transfer in immediately available funds to an account designated by KIT.", "samples": [{"hash": "k5ryoXjyNp5", "uri": "/contracts/k5ryoXjyNp5#currency-payment-method", "label": "Pre Clinical Development Collaboration Agreement (Isis Pharmaceuticals Inc)", "score": 21.0, "published": true}], "hash": "48efec7a854ea1f59799830902139f3c", "id": 7}, {"size": 1, "snippet_links": [{"key": "dollar-amounts", "type": "definition", "offset": [10, 24]}, {"key": "in-this-agreement", "type": "definition", "offset": [37, 54]}, {"key": "united-states-dollars", "type": "clause", "offset": [59, 80]}, {"key": "payments-to", "type": "clause", "offset": [86, 97]}, {"key": "in-united-states", "type": "clause", "offset": [137, 153]}, {"key": "by-check", "type": "clause", "offset": [162, 170]}, {"key": "payable-to", "type": "definition", "offset": [171, 181]}, {"key": "due-date", "type": "definition", "offset": [280, 288]}, {"key": "equal-to", "type": "definition", "offset": [311, 319]}, {"key": "per-month", "type": "clause", "offset": [328, 337]}, {"key": "maximum-allowed", "type": "clause", "offset": [342, 357]}], "snippet": "3.3.1 All dollar amounts referred to in this AGREEMENT are United States dollars. All payments to INO under this AGREEMENT shall be made in United States dollars by check payable to \u201cInovio Pharmaceuticals.\u201d\n3.3.2 Amounts that are not paid when due shall accrue interest from the due date until paid, at a rate equal to [*****] per month (or maximum allowed by law, if less).", "samples": [{"hash": "l8Gw69oTuvr", "uri": "/contracts/l8Gw69oTuvr#currency-payment-method", "label": "Cross License Agreement (ONCOSEC MEDICAL Inc)", "score": 22.4483222961, "published": true}], "hash": "88248eac22610cb6dbeff763c0b7ffea", "id": 8}, {"size": 1, "snippet_links": [{"key": "payments-under-this-agreement", "type": "clause", "offset": [4, 33]}, {"key": "by-wire-transfer", "type": "clause", "offset": [88, 104]}, {"key": "automated-clearing-house", "type": "definition", "offset": [108, 132]}, {"key": "payment-to", "type": "clause", "offset": [133, 143]}, {"key": "applicable-party", "type": "definition", "offset": [173, 189]}, {"key": "each-party", "type": "definition", "offset": [205, 215]}, {"key": "from-time-to-time", "type": "clause", "offset": [227, 244]}, {"key": "in-writing", "type": "clause", "offset": [245, 255]}], "snippet": "All payments under this Agreement are expressed in Dollars and will be paid in Dollars, by wire transfer or automated clearing house payment to an account designated by the applicable Party, which account each Party may update from time to time in writing.", "samples": [{"hash": "ftH5OuWFDQR", "uri": "/contracts/ftH5OuWFDQR#currency-payment-method", "label": "Collaboration and License Agreement (Novavax Inc)", "score": 33.6009597778, "published": true}], "hash": "cacc761a931acd8481ac52f2ed55575d", "id": 9}, {"size": 1, "snippet_links": [{"key": "payments-under-this-agreement", "type": "clause", "offset": [4, 33]}, {"key": "transfer-to", "type": "definition", "offset": [137, 148]}, {"key": "from-time-to-time", "type": "clause", "offset": [218, 235]}, {"key": "in-writing", "type": "clause", "offset": [236, 246]}, {"key": "amounts-to-be-paid", "type": "clause", "offset": [306, 324]}, {"key": "agreement-or", "type": "definition", "offset": [336, 348]}, {"key": "dollar-equivalent", "type": "definition", "offset": [499, 516]}, {"key": "standard-procedures", "type": "definition", "offset": [547, 566]}, {"key": "rate-methodology", "type": "clause", "offset": [629, 645]}, {"key": "foreign-currency", "type": "definition", "offset": [669, 685]}, {"key": "in-the-case", "type": "clause", "offset": [717, 728]}, {"key": "consistently-applied", "type": "definition", "offset": [772, 792]}, {"key": "calculation-of-net-sales", "type": "clause", "offset": [794, 818]}, {"key": "foreign-exchange", "type": "definition", "offset": [844, 860]}, {"key": "gain-or-loss", "type": "clause", "offset": [861, 873]}, {"key": "hedging-program", "type": "definition", "offset": [893, 908]}], "snippet": "All payments under this Agreement are expressed in U.S. Dollars and will be paid in U.S. Dollars, in immediately available funds by wire transfer to an account designated by GenFleet (which account GenFleet may update from time to time in writing). If any amounts that are relevant to the determination of amounts to be paid under this Agreement or any calculations to be performed under this Agreement are denoted in a currency other than U.S. Dollars, such amounts will be converted to their U.S. Dollar equivalent using Verastem\u2019s then-current standard procedures and methodology, including its then-current standard exchange rate methodology for the translation of foreign currency expenses into U.S. Dollars or, in the case of Sublicensees, such similar methodology, consistently applied. Calculation of Net Sales will exclude hedging and foreign exchange gain or loss realized through a hedging program. \u200b \u200b", "samples": [{"hash": "6iTLgDBRxkg", "uri": "/contracts/6iTLgDBRxkg#currency-payment-method", "label": "Collaboration and Option Agreement (Verastem, Inc.)", "score": 36.2142372131, "published": true}], "hash": "18dcc839d1d9c7fe7161ad38174ac610", "id": 10}], "next_curs": "CmASWmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjwLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IiBjdXJyZW5jeS1wYXltZW50LW1ldGhvZCMwMDAwMDAwYQyiAQJlbhgAIAA=", "clause": {"size": 29, "title": "Currency; Payment Method", "parents": [["payment-terms", "Payment Terms"], ["financial-provisions", "Financial Provisions"], ["fees-and-royalties", "Fees and Royalties"], ["early-development", "Early Development"], ["subcontracts", "Subcontracts"]], "children": [], "id": "currency-payment-method", "related": [["payment-method", "Payment Method", "Payment Method"], ["settlement-method", "Settlement Method", "Settlement Method"], ["payment-methodology", "Payment Methodology", "Payment Methodology"], ["payment-methods", "Payment Methods", "Payment Methods"], ["civil-penalty-payment-method", "Civil Penalty Payment Method", "Civil Penalty Payment Method"]], "related_snippets": [], "updated": "2026-02-07T05:29:46+00:00", "also_ask": [], "drafting_tip": "Specify the currency and payment method to prevent disputes; require written agreement for changes to ensure clarity; define timing of payments to avoid delays.", "explanation": "The 'Currency; Payment Method' clause defines the specific type of currency in which payments under the agreement must be made and outlines the acceptable methods for making those payments. Typically, this clause will state whether payments should be made in U.S. dollars, euros, or another currency, and may specify if payments are to be made via wire transfer, check, or other means. By clearly establishing these terms, the clause helps prevent disputes or confusion regarding payment logistics, ensuring both parties understand their obligations and reducing the risk of delays or errors in financial transactions."}, "json": true, "cursor": ""}}